Rediff Logo
Money
Line
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Wedding | Women
Partner Channels: Bill Pay | Health | IT Education | Jobs | Technology | Travel
Line
Home > Money > Reuters > Report
June 25, 2001
Feedback  
  Money Matters

 -  Business Special
 -  Business Headlines
 -  Corporate Headlines
 -  Columns
 -  IPO Center
 -  Message Boards
 -  Mutual Funds
 -  Personal Finance
 -  Stocks
 -  Tutorials
 -  Search rediff

    
      



 
Reuters
 Search the Internet
         Tips
 Sites: Finance, Investment
E-Mail this report to a friend
Print this page

Dr Reddy's starts online clinical trials

Dr Reddy's Laboratories said on Monday it had become the first Indian drugmaker to go on-line with all the data from its late phase drug clinical trials.

Dr Reddy's Labs said in a statement it would use the website www.drreddysct.com to capture and analyse clinical data from centres at which phase III and phase IV clinical trials were carried out.

Phase III trials are the final trials before a drug goes to market. They test a drug's safety and efficacy on a large number of patients.

Phase IV trials are carried out after a drug hits the market to verify that it has no adverse effects.

The statement said the online procedure was being used to link trials being carried out on the antibiotic gatifloxacin and the anti-asthma drug zafirlukast in five Indian cities.

The company estimates the on-line route will cut to one week from six the time required to prepare a clinical report.

Dr Reddy's shares closed up 2.26 per cent at Rs 1,534 on Monday. The Bombay benchmark index closed down 1.87 per cent.

Back to top
(c) Copyright 2000 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Tell us what you think of this report